Impact of Inflammatory Response Modifiers on the Incidence of Hospital-Acquired Infections in Patients with COVID-19

INTRODUCTION: The study aim was to assess the influence of inflammatory response modifiers, including anti-interleukin-6 (IL-6) biologics and corticosteroids, on the incidence of hospital-acquired infections in patients with coronavirus disease 2019 (COVID-19). METHODS: Case–control study performed...

Descripción completa

Detalles Bibliográficos
Autores principales: Meira, Fernanda, Moreno-García, Estela, Linares, Laura, Macaya, Irene, Tomé, Adria, Hernández-Meneses, Marta, Albiach, Laia, Morata, Laura, Letona, Laura, Bodro, Marta, Cózar-Llistó, Alberto, Cardozo, Celia, Chumbita, Mariana, Pitart, Cristina, Ambrosioni, Juan, Rico, Verónica, Agüero, Daiana, Puerta-Alcalde, Pedro, Garcia-Pouton, Nicole, Marco, Francesc, Garcia-Vidal, Carolina, Soriano, Alex, Martínez, José Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8193595/
https://www.ncbi.nlm.nih.gov/pubmed/34115314
http://dx.doi.org/10.1007/s40121-021-00477-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8193595/
https://www.ncbi.nlm.nih.gov/pubmed/34115314
http://dx.doi.org/10.1007/s40121-021-00477-9

Ejemplares similares